The 37 references in paper Kh. Markov M., Х. Марков М. (2014) “Хроническая легочная гипертония и система оксида азота // Chronic pulmonary hypertension and nitric oxide” / spz:neicon:pulmonology:y:2012:i:1:p:88-94

1
Romberg E.Uber sclerose der lungenarterie. Dtsch. Arch. Klin. Med. 1891; 48: 197–206.
(check this in PDF content)
2
Coggion M.P., Bloch K.Nitric oxide in the pulmonary vasculature. Arterioscler. Thromb. Vasc. Biol. 2007; 27: 1877–1885.
(check this in PDF content)
3
Steudel O.V., Scherrer-Grosbi M., Bloch K.D. et al. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of eNOS. J. Clin. Invest. 1998; 101: 2468–2477.
(check this in PDF content)
4
Fagan K.A., Nyler R.C., Sato K. et al.Relative contribution of eNOS, iNOS and nNOS to (tone) in the marine pulmonary circulation. Am. J. Physiol. 1999; 277: L472–L478.
(check this in PDF content)
5
Hampl V., Herget J. Role of NO in the pathogenesis of pulmonary hypertension. Physiol. Rev. 2000; 80: 1337–1372.
(check this in PDF content)
6
Moutgil R., Michelakis E.D., Archer S.L.Hypoxic pulmonary vasoconstriction. J. Appl. Physiol. 2005; 98: 390–403.
(check this in PDF content)
7
Murata T., Sato K., Hori M. et al. Decreased eNOS activity resulting from abnormal interaction between eNOS and its regulatory protein in hyxoxia-induced oulmonary hypertension. J. Biol. Chem. 2002; 277: 1485–1492.
(check this in PDF content)
8
Naage J., Valen G.Preconditioning and cardiac surgery. Ann. Thorac. Surg. 2003; 75: S709–S714.
(check this in PDF content)
9
Kielstein J.T., Bode-Boger S.M., Hesse G. et al. Asymmetric dimethylarginine in idiopatic pulmonary arterial hypertension. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 1414–1418.
(check this in PDF content)
10
Leiper J., Nandi M., Torondel B. et al. Disrubtion of methylarginine metabolism impairs vascular homeostasis. Nature Med. 2007; 13: 198–203.
(check this in PDF content)
11
Khoo L.P., Zhao L., Alp N.J. et al.Role of endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation 2008; 111: 2126–2133.
(check this in PDF content)
12
Giaid A., Salch D. Reduced expression of eNOS in the lung of patients with pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2005; 172: 352–357.
(check this in PDF content)
13
Zeiher A.M., Schachinger V., Minners J.Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094–1100.
(check this in PDF content)
14
Barbera J.A., Peinado V.I., Santos S. et al.Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am. J. Respir. Crit. Care Med. 2001; 164 (4): 709–713.
(check this in PDF content)
15
Assreuy J., Cunha F.Q., Liew F.Y., Moncada S.Feedback inhibition of NOS-activity by nitric oxide. Br. J. Pharmacol. 1993; 108: 833–837.
(check this in PDF content)
16
Su Y., Han W., Giraldo C. et al.Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 1998; 19: 819–825.
(check this in PDF content)
17
Griffits M.J.D., Evans T.W. Inhaled NO therapy in adults. N. Engl. J. Med. 2005; 353: 2683–2695.
(check this in PDF content)
18
Ishinose F., Roberts J.D., Zapol W.M.Inhaled NO: a selective pulmonary vasodilator current uses and therapeutic potential. Circulation 2004; 109: 3106–3111.
(check this in PDF content)
19
Sitbon O., Brenot F., Denjean A. et al. Inhaled NO as a screening vasodilator agent in primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1995; 151: 384–389.
(check this in PDF content)
20
Taylor R.W., Zimmerman J.L., Dellinger R.P. et al.Low-dose inhaled NO in patients with acute lung injury: a randomized controlled trial. J.A.M.A. 2004; 291: 1603–1609.
(check this in PDF content)
21
Brandler M.D., Powell S.C., Craig D.M. et al. A novel inhaled organic nitrate that affects pulmonary vascular tone in a piglet model of hypoxia-induced pulmonary hypertension. Pediatr. Res. 2005; 58: 531–536.
(check this in PDF content)
22
Hanter C.J., Dejam A., Blood A.B. et al. Inhaled nebulized nitrit is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nature Med. 2004; 10: 1122–1127.
(check this in PDF content)
23
Michelakis E.D.Soluble guanylate cyclase as a potential therapy for pulmonary arterial hypertension. Eur. Respir. J. 2009; 33 (4): 717–721.
(check this in PDF content)
24
Wilkens H., Guth A., Konig J. et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary circulation. Circulation 2001; 104: 1218–1222.
(check this in PDF content)
25
Fesler P., Pagnamenta A., Rondelet B. et al. Effects of sildenafil on hypoxic pulmonary vascular function in dogs. J. Appl. Physiol. 2006; 101: 1085–1090.
(check this in PDF content)
26
Mermuly R.T., Kreisselmeier K.P., Chofrani H.A. et al. Chronic sildenafil treatment inhibits monocrotalineinduced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2004; 169: 39–45.
(check this in PDF content)
27
Mondelet B., Kerbanl F., Fireston L. et al.Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effect of sildenafil therapie. Circulation 2004; 110: 2220–2225.
(check this in PDF content)
28
Ghofrani H.A., Schermuly R.T., Rose F. et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2003; 167: 1139–1141.
(check this in PDF content)
29
Ghofrani H.A., Grimminger F. Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy. Eur. Respir. Rev. 2009; 18: 35–41.
(check this in PDF content)
30
Grimminger F., Weimann G., Frey R. et al. First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension. Eur. Respir. J. 2009; 33: 785–792.
(check this in PDF content)
31
Girgis R.E., Zhan X., Garcia J.G.N. et al.Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am. J. Physiol. 2003; 285: H938–H945. Марков Х.М. Хроническая легочная гипертония и система оксида азота
(check this in PDF content)
32
Murata T., Kinoshita K., Hori M. et al. Statin protects eNOS activity in hypoxia-induced pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 2335–2342.
(check this in PDF content)
33
Champion H.C., Bivalacqwa T.J., Greenberg S.S. et al. Adenoviral gene transfer of eNOS partially restores normal pulmonary arterial pressure in eNOS-deficient micc. Proc. Natl Acad. Sci. USA 2002; 92: 13248–13253.
(check this in PDF content)
34
Sata M. Role of circulating vascular progenitors in angiogenesis vascular healing and pulmonary hypertension: lessons from animal models. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 1008–1014.
(check this in PDF content)
35
Zhao Y.D., Courtman D.W., Deng Y. et al. Rescue of pulmonary hypertension using endothelial-like progenitor cells. Circ. Res. 2005; 96: 442–450.
(check this in PDF content)
36
Kanki-Horimoto S., Horimoto H., Mieno S. et al. Implantation of mesenchimal stem cell overexpressing eNOS improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006; 114: 181–185.
(check this in PDF content)
37
Russwurm M., Mergia E., Mulleshausen F. et al. Inhibition of deactivation of NO-sensitive guanylyl cyclase account for the sensitizing effect of YC-1. J. Biol. Chem. 2002; 277: 24883–24888. Информация об авторе
(check this in PDF content)